Artivion (AORT) EPS (Basic) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Artivion | 1.02 Bn | 961.00 Mn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.89% |
| Dec 31, 2025 | 21.67% |
| Sep 30, 2025 | 30.26% |
| Jun 30, 2025 | 18.13% |
| Mar 31, 2025 | 43.90% |
| Dec 31, 2024 | -108.07% |
| Sep 30, 2024 | -69.11% |
| Jun 30, 2024 | -21.29% |
| Mar 31, 2024 | 82.06% |
| Dec 31, 2023 | -37.97% |
| Sep 30, 2023 | -51.57% |
| Jun 30, 2023 | -58.49% |
| Mar 31, 2023 | -24.57% |
| Dec 31, 2022 | 20.64% |
| Sep 30, 2022 | -60.04% |
| Jun 30, 2022 | -26.37% |
| Mar 31, 2022 | -25.74% |
| Dec 31, 2021 | -50.29% |
| Sep 30, 2021 | 24.57% |
| Jun 30, 2021 | -23.36% |
| Mar 31, 2021 | -24.57% |
| Dec 31, 2020 | -24.57% |
| Sep 30, 2020 | -24.57% |
| Jun 30, 2020 | -37.97% |
| Mar 31, 2020 | -78.26% |
| Dec 31, 2019 | -16.72% |
| Sep 30, 2019 | -15.38% |
| Jun 30, 2019 | 0.00% |
| Mar 31, 2019 | -17.61% |
| Dec 31, 2018 | -15.56% |
| Sep 30, 2018 | -18.32% |
| Jun 30, 2018 | -30.12% |
| Mar 31, 2018 | -27.54% |
| Dec 31, 2017 | -25.59% |
| Sep 30, 2017 | -7.79% |
| Jun 30, 2017 | -5.59% |
| Mar 31, 2017 | 11.84% |
| Dec 31, 2016 | 8.45% |
| Sep 30, 2016 | 5.15% |
| Jun 30, 2016 | 3.13% |
| Mar 31, 2016 | 5.92% |
| Dec 31, 2015 | 5.15% |
| Sep 30, 2015 | 22.22% |
| Jun 30, 2015 | -17.08% |